Medical Information
In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Dobutamine Injection, USP is supplied in 20 mL single-dose glass vials containing 250 mg dobutamine, as the hydrochloride as follows:
| Unit of Sale | Concentration | Each |
|---|---|---|
| NDC 0409-2344-01 Carton containing 1 Vial | 250 mg/20 mL (12.5 mg/mL) | NDC 0409-2344-01 20 mL Single-Dose Vial |
| NDC 0409-2344-02 Tray containing 10 Vials | 250 mg/20 mL (12.5 mg/mL) | NDC 0409-2344-62 20 mL Single-Dose Vial |
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.
